Company Insights
Axon to buy emergency dispatch startup Prepared
Taser and bodycam maker Axon announced Tuesday that it would acquire Prepared, an emergency communications platform.
Section
Company Insights
Company Insights
Trump’s Unpredictable Pharma Policies Could Pinch Thermo Fisher’s Bottom Line
President Trump’s tariff hike and drug pricing agenda have injected fresh uncertainty into the pharmaceutical sector. Thermo Fisher Scientific could end up caught in the crossfire.
Coinbase
Coinbase and Cloudflare Launch x402 Foundation to Develop AI-Payment Ecosystem
Coinbase Global Inc. (COIN) and Cloudflare Inc.
Company Insights
Olive Garden Tests New Lower Portion, Lower Price Menu
Olive Garden is quietly testing out a new menu for customers with smaller budgets and smaller appetites.
Avangrid
NextEra Energy clears antitrust hurdle over New England grid
NextEra Energy, Inc. notched a legal victory on Sept.
Gap
Apparel Retail Industry Rises Despite Tariffs
Denim made its return this summer to Gap Inc. and American Eagle Outfitters, Inc.’s window displays.
Energy
GE Vernova CEO confident in wind power despite political headwinds
Company still set to benefit from gas and nuclear policy Some think wind power still has a future in the US, even if its president thinks it is “the scam of the century.
American Eagle
Viral denim campaigns lifted American Eagle and Gap shares. Will the rallies last?
Ads starring Sydney Sweeney and KATSEYE gave two household jeans names a boost on Wall Street.
Company Insights
SiriusXM bets on flashy podcast deals and lower prices to attract younger listeners
Listeners of Gen-Z female-targeted podcast ‘Call Her Daddy’ reacted with a mix of dismay, confusion, and excitement when SiriusXM announced they were signing its host Alex Cooper and her network ‘Unwell’ to a $125 million dollar deal.
AT&T’s Fiber Network is Winning but Competition is Catching Up. Does it Need To Keep Expanding?
AT&T has the largest fiber network in the US, but risks falling behind if it doesn’t continue to expand at a rapid clip.
Company Insights
Eli Lilly believes its drugs could treat ailments beyond obesity. Accessibility challenges and a Trump admin stand in the way
As pharmaceutical giant Eli Lilly evolves its popular obesity and diabetes drug, the company has discovered positive side effects that could develop into spin-off medications.
Earnings
Snap Struggles To Grow In Its Most Important Market
Snap’s user growth in North America – its most important market – fell troublingly flat in the third quarter.